Intel Declines; Dynavax Rallies; Nike Ticks Higher
Affected assets and topics
Why it matters
Intel shares decline due to Nvidia halting a test using Intel's 18A technology, while Dynavax shares surge after Sanofi agrees to buy the company for $2.2 billion, and Nike shares tick higher following Apple CEO Tim Cook's $2.95 million share purchase.
Article tone
Expected market reaction
Moderate market impact, with Intel's decline potentially affecting the semiconductor sector and Dynavax's surge influencing the biotech industry. Nike's move is relatively isolated and may have a limited impact on the broader market.
Evidence trail
Evidence
AI provenance
Technical identifiers
- Provider tag
- groq-llama-3.1-8b-instant
- Analysis version
- groq-llama-3.1-8b-instant
- Article id
- 26160
Original source
- Shares of Intel (INTC) fell in the early session after Reuters reported that Nvidia halted a test that uses the chip manufacturer’s 18A technology to produce its chips. - Shares of Dynavax Technologies (DVAX) soared in premarket trading after Sanofi agreed to buy Dynavax for about $2.2 billion, as it seeks to expand a vaccines business currently anchored by its flu shot franchise. The French drugmaker will pay $15.50 a share in cash for Dynavax, 39% above the Emeryville, California-based firm’s closing price Tuesday. - Shares of Nike (NKE) moved higher ahead of the US market open after a filing shows that Apple CEO Tim Cook purchased $2.95 million worth of shares on December 22nd. (Source: Bloomberg)
Read the full article on Bloomberg
Original article published by Bloomberg on December 24, 2025. Analysis and insights provided by AnalystMarkets AI.